Cardiovascular Medicine
Cardiovascular Medicine Faculty
 |
R. David Anderson, M.D., F.A.C.C. Division of Cardiovascular Medicine Associate Professor of Medicine Director, Interventional Cardiology e-mail: david.anderson@medicine.ufl.edu 1600 SW Archer Road/Box 100277 Gainesville, FL 32610-0277 352 392 0092/FAX 352 846 0314 |
Training:
| Degree Program |
Institution | Field/Specialty |
| BSME | Stevens Institute of Technology | Mechanical Engineering |
| MS with Thesis | University of Pennsylvania | Biochemistry |
| MD | Johns Hopkins University School of Medicine | |
| Residency | University of Maryland Hospital | Internal Medicine |
| Chief Resident | University of Maryland Hospital | |
| Fellowship | Duke University Medical Center | Cardiovascular Medicine |
Academic Interests:
Dr. Anderson has continued interest and participation in clinical trials of device and drug development for acute coronary syndromes. Interests also include the application of rotational atherectomy, distal protection, as well as thrombectomy to the treatment of coronary artery disease. Additionally his interests include the endovascular treatment of peripheral arterial disease. Dr. Anderson has participated in the design and execution of multiple clinical trials involving the use of angiogenesis growth factors in the treatment of peripheral arterial disease. He is an active member of the American College of Cardiology as well as the Florida Chapter of the ACC and the Society of Coronary Angiography and Intervention. He is a founding member of the Society of Cardiovascular Computer Tomography.
Clinical Interests:
Interventional Cardiology, Peripheral vascular intervention, Percutaneous Treatment of Valvular Disease, Clinical Trials
Representative Publications:
- Singh M, Reeder GS, Ohman EM, Mathew V, Hillegass WB, Anderson RD, Gallup DS, Garrett KN, Holmes DR. Does the presence of thrombus seen on a coronary angiogram affect outcome after percutaneous coronary angioplasty? An angiographic trials pool data experience. J Am Coll Cardiol 2001;38:624-630.
- Lederman RJ, Medelsohn FO, Anderson RD, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor – 2 for intermittent claudication (the TRAFFIC study): a randomized trial. Lancet 2002;359:2053-2058.
- Anderson RD, White HD, Ohman EM, Wagner GS, et al. Predicting outcome after Thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: A substudy of the GUSTO-III trial. Am Heart J 2002;144(1):81-8.
- Grossman P, Anderson RD, et al. Day 180 Results from a phase II Multi-center, Double blind Placebo-controlled study of VLTS-589 for intermittent claudication in subjects with peripheral arterial disease. Abstract presentation at American Heart Association 2005.
Visit Pubmed for full list of publications